Literature DB >> 20182702

Anticholinergic effects of cis- and trans-isomers of two metabolites of propiverine.

Stefan Propping1, Manfred Braeter, Marc-Oliver Grimm, Manfred P Wirth, Ursula Ravens, Melinda Wuest.   

Abstract

The muscarinic receptor antagonist propiverine used for therapy of overactive bladder undergoes first pass metabolism, leading to several active metabolites, which affect muscarinic receptors and L-type Ca(2+) channels with different potencies. M-5, the major metabolite in blood, and M-6 can be synthesized as cis- and trans-isomers. We systematically investigated the pharmacodynamic profiles of the isomers on detrusor contractile function. In murine and porcine detrusor, the effects of the derivatives were examined on contractions induced by electric field stimulation (EFS), cumulatively increasing concentrations of carbachol or high KCl concentration. EFS contractions were concentration-dependently reduced by the M-5 and M-6 isomers although to a different extent. M-5(cis) was slightly more potent than M-5(trans), but the differences did not reach statistical significance. M-6(cis) was significantly more potent than M-6(trans). Responses to carbachol were antagonized by all compounds due to rightward shifts of the concentration-response curves, but only M-5(trans) also significantly reduced the maximum response. pK (B) values obtained with Schild plot analysis indicated slightly higher potency for M-6(cis) than M-6(trans). Ca(2+) influx-dependent contractions elicited by K(+) depolarization were less impaired by low concentrations of the M-6 isomers, but strongly suppressed by 100 microM of the M-5 isomers, suggesting an additional effect of the two M-5 isomers on Ca(2+) influx. All investigated isomers of M-5 and M-6 are biologically active in reducing detrusor contraction in animal tissue. While M-5( cis,) M-6(cis), and M-6(trans) possess surmountable or partially surmountable antagonistic properties at muscarinic receptors, M-5(trans) is a strong non-competitive antagonist. However, at higher concentration ranges, all four compounds seem to have additional effects on Ca(2+) influx.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20182702     DOI: 10.1007/s00210-010-0493-x

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  34 in total

Review 1.  Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder.

Authors:  Paul Abrams; Karl-Erik Andersson; Jerry J Buccafusco; Christopher Chapple; William Chet de Groat; Alison D Fryer; Gary Kay; Alan Laties; Neil M Nathanson; Pankaj Jay Pasricha; Alan J Wein
Journal:  Br J Pharmacol       Date:  2006-06-05       Impact factor: 8.739

Review 2.  Urgency: the key to defining the overactive bladder.

Authors:  Paul Abrams
Journal:  BJU Int       Date:  2005-09       Impact factor: 5.588

Review 3.  The cellular basis of contraction in human detrusor smooth muscle from patients with stable and unstable bladders.

Authors:  Christopher H Fry; Deborah Skennerton; Dan Wood; Changhao Wu
Journal:  Urology       Date:  2002-05       Impact factor: 2.649

4.  Human idiopathic and neurogenic overactive bladders and the role of M2 muscarinic receptors in contraction.

Authors:  Laurie A Stevens; Christopher R Chapple; Russ Chess-Williams
Journal:  Eur Urol       Date:  2006-11-15       Impact factor: 20.096

Review 5.  The L-arginine/nitric oxide pathway and non-adrenergic, non-cholinergic relaxation of the lower urinary tract.

Authors:  K E Andersson; K Persson
Journal:  Gen Pharmacol       Date:  1993-07

6.  Pharmacodynamics of propiverine and three of its main metabolites on detrusor contraction.

Authors:  Melinda Wuest; Juliane Hecht; Torsten Christ; Manfred Braeter; Christian Schoeberl; Oliver W Hakenberg; Manfred P Wirth; Ursula Ravens
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

7.  Mechanical response to electrical field stimulation of rat, guinea-pig, monkey and human detrusor muscle: a comparative study.

Authors:  F Pessina; K Marazova; R Kalfin; G Sgaragli; A Manganelli; K Milenov
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2001-05       Impact factor: 3.000

Review 8.  Muscarinic receptor subtypes in the lower urinary tract.

Authors:  Daniel Giglio; Gunnar Tobin
Journal:  Pharmacology       Date:  2009-03-19       Impact factor: 2.547

Review 9.  Describing bladder storage function: overactive bladder syndrome and detrusor overactivity.

Authors:  Paul Abrams
Journal:  Urology       Date:  2003-11       Impact factor: 2.649

Review 10.  Muscarinic receptor antagonists for overactive bladder.

Authors:  Paul Abrams; Karl-Erik Andersson
Journal:  BJU Int       Date:  2007-11       Impact factor: 5.588

View more
  3 in total

1.  The muscarinic receptor antagonist propiverine exhibits α(1)-adrenoceptor antagonism in human prostate and porcine trigonum.

Authors:  Melinda Wuest; Lambertus P Witte; Martina B Michel-Reher; Stefan Propping; Manfred Braeter; Gerhard J Strugala; Manfred P Wirth; Martin C Michel; Ursula Ravens
Journal:  World J Urol       Date:  2011-02-19       Impact factor: 4.226

Review 2.  Propiverine: a review of its use in the treatment of adults and children with overactive bladder associated with idiopathic or neurogenic detrusor overactivity, and in men with lower urinary tract symptoms.

Authors:  Kate McKeage
Journal:  Clin Drug Investig       Date:  2013-01       Impact factor: 2.859

3.  Human Urinary Bladder Strip Relaxation by the β-Adrenoceptor Agonist Isoprenaline: Methodological Considerations and Effects of Gender and Age.

Authors:  Tim Schneider; Charlotte Fetscher; Martin C Michel
Journal:  Front Pharmacol       Date:  2011-02-25       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.